Evidence map›Paper›PMID 38622434›Full record

SynthesisEndocrine2024

Interventions to improve symptomatology in patients with hypothyroidism and persistent symptoms: A systematic review.

Jessica Hidalgo, Eddy P Lincango, Sandra Cordova-Madera, Kim Ruiz-Arellanos, Camila Wenczenovicz, Oscar Ponce, Neri Álvarez-Villalobos, Arbaaz Rao, Naykky M Singh Ospina, Spyridoula Maraka and 2 more

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Endocrine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 4 countries.

Jessica HidalgoKnowledge and Evaluation Research Unit in Endocrinology, Mayo Clinic, Rochester, MN, USA.
Eddy P LincangoKnowledge and Evaluation Research Unit in Endocrinology, Mayo Clinic, Rochester, MN, USA.
Sandra Cordova-MaderaDepartment of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Kim Ruiz-ArellanosFacultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Peru.
Camila WenczenoviczKnowledge and Evaluation Research Unit in Endocrinology, Mayo Clinic, Rochester, MN, USA.
Oscar PonceKnowledge and Evaluation Research Unit in Endocrinology, Mayo Clinic, Rochester, MN, USA.
Neri Álvarez-VillalobosFacultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Arbaaz RaoRutgers Health Community Medical Center, Internal Medicine, Toms River, NJ, USA.
Naykky M Singh OspinaDivision of Endocrinology, Department of Medicine, University of Florida, Gainesville, FL, USA.
Spyridoula MarakaDivision of Endocrinology and Metabolism, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Gonzalo J AcostaDivision of Endocrinology, Department of Medicine, University of Florida, Gainesville, FL, USA.
Juan P BritoDivision of Diabetes, Endocrinology, Metabolism, and Nutrition, Department of Medicine, Mayo Clinic, Rochester, MN, USA. brito.juan@mayo.edu.ORCID 0000-0003-1840-1745
Rutgers, The State University of New Jersey · USUniversity of Florida · USAlbert Einstein College of Medicine · USCentral Arkansas Veterans Healthcare System · USFrimley Health NHS Foundation Trust · GBMayo Clinic · USMayo Clinic in Florida · USUniversidad Autónoma de Nuevo León · MXUniversidad Peruana Cayetano Heredia · PEUniversity of Central Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLevothyroxine (LT4) monotherapy is the standard treatment for hypothyroidism; however, 10-15% of patients have persistent hypothyroid symptoms despite normalizing thyroid hormone levels with LT4. This study aims to summarize the best available evidence on interventions to improve symptomatology in patients with hypothyroidism and persistent symptoms.

methodsA systematic search was conducted in March 2022 for randomized controlled trials and observational studies on interventions for adult patients with persistent hypothyroid symptoms despite biochemical euthyroidism on thyroid hormone replacement.

resultsA total of 277 articles were reviewed and seven fulfilled the inclusion criteria. 455 participants were included. Most intervention participants were female (78.6%) with a mean age of 47.5 (±2.8) years. Five clinical trials evaluating ginger (vs. starch), L-carnitine (vs. placebo), combination LT4 and liothyronine (LT3) (vs. LT4 or placebo), and surgery for patients with serum antithyroid peroxidase (TPO Ab) titers greater than 1000 IU/ml (vs. LT4) found inconsistent improvement in hypothyroidism related symptoms and general health. The two clinical trials with the largest improvement in fatigue scores were the use of ginger and surgery. One observational study comparing thyroidectomy vs observation found no significant difference on general health. Lastly, another observational study evaluating combination LT4/LT3 (vs. LT4 monotherapy) found improvement in fatigue and quality of life. There were 31 (12%) adverse events in the intervention group and 18 (10.8%) in the comparator group.

conclusionsThere is no high-quality evidence supporting any intervention for persistent symptoms in hypothyroidism. Available evidence, limited by the risk of bias, inconsistency, and heterogeneity, suggests that some persistent symptoms, particularly fatigue, could improve with ginger and thyroidectomy.

Indexed as

HypothyroidismAdultFemaleHormone Replacement TherapyHumansMaleMiddle AgedThyroidectomyThyroxineZingiber officinaleThyroxineHypothyroidPersistent symptomsQuality of lifeThyroid hormone

Identifiers

PMID38622434
OpenAlexW4394805325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.